Results 131 to 140 of about 9,808 (206)

In silico identification of bilobetin and ginsenoside as dual CK2 and ULK2 inhibitors targeting triple-negative breast cancer. [PDF]

open access: yesSci Rep
Hossain MA   +17 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy